We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+9.76%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.3B
AUM Growth
+$92.1M
(+7.6%)
Cap. Flow
+$25M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
36.27%
Holding
543
New
63
Increased
193
Reduced
214
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra Gold
UGL
|
+$16.2M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$6.26M |
| 3 |
Micron Technology
MU
|
+$4.07M |
| 4 |
Meta Platforms (Facebook)
META
|
+$3.94M |
| 5 |
Ferrari
RACE
|
+$2.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$11.5M |
| 2 |
iShares Silver Trust
SLV
|
+$7.75M |
| 3 |
Amazon
AMZN
|
+$6.78M |
| 4 |
Oracle
ORCL
|
+$2.75M |
| 5 |
Royal Caribbean
RCL
|
+$2.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.86% |
| 2 | Healthcare | 22.63% |
| 3 | Communication Services | 13.04% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Consumer Staples | 2.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Castle Biosciences
CSTL
$960M
| $185K | 0.01% |
4,756
-329
| -6% | -$10.6K |
|
352
Pacira BioSciences
PCRX
$945M
| $181K | 0.01% |
7,010
-866
| -11% | -$20.6K |
|
353
Annexon
ANNX
$873M
| $181K | 0.01% |
36,084
+823
| +2% | +$3.15K |
|
354
UroGen Pharma
URGN
$2.39B
| $179K | 0.01% |
7,627
-482
| -6% | -$10.5K |
|
355
Xencor
XNCR
$1.72B
| $178K | 0.01% |
11,636
-866
| -7% | -$12.9K |
|
356
Novavax
NVAX
$1.31B
| $178K | 0.01% |
26,479
-1,991
| -7% | -$15K |
|
357
Sana Biotechnology
SANA
$1.13B
| $177K | 0.01% |
43,404
-1,943
| -4% | -$8.7K |
|
358
Iovance Biotherapeutics
IOVA
$3.05B
| $177K | 0.01% |
64,686
+1,258
| +2% | +$2.91K |
|
359
Tandem Diabetes Care
TNDM
$1.63B
| $176K | 0.01% |
8,000
| – | – |
|
360
Globus Medical
GMED
$11.5B
| $175K | 0.01% |
2,000
-3,000
| -60% | -$228K |
|
361
Erasca
ERAS
$6.45B
| $172K | 0.01% |
46,231
-3,492
| -7% | -$9.82K |
|
362
Insulet
PODD
$10.1B
| $171K | 0.01% |
+600
| New | +$188K |
|
363
Intellia Therapeutics
NTLA
$1.69B
| $170K | 0.01% |
18,874
-19,942
| -51% | -$275K |
|
364
Li Auto
LI
$12.2B
| $169K | 0.01% |
10,000
-20,000
| -67% | -$396K |
|
|
PVLA
365
Palvella Therapeutics
PVLA
$2.23B
| $167K | 0.01% |
+1,600
| New | +$136K |
|
366
AbCellera Biologics
ABCL
$3.18B
| $167K | 0.01% |
48,777
-3,604
| -7% | -$16.1K |
|
367
Diageo
DEO
$52.2B
| $163K | 0.01% |
1,884
-2,233
| -54% | -$206K |
|
368
Procept Biorobotics
PRCT
$1.22B
| $157K | 0.01% |
5,000
-3,000
| -38% | -$99.5K |
|
|
DAWN
369
DELISTED
Day One Biopharmaceuticals
DAWN
| $156K | 0.01% |
16,731
-1,224
| -7% | -$10.2K |
|
|
ALMS
370
Alumis Inc
ALMS
$3.26B
| $155K | 0.01% |
15,840
-1,142
| -7% | -$7.97K |
|
371
Theravance Biopharma
TBPH
$878M
| $154K | 0.01% |
8,257
-571
| -6% | -$9.47K |
|
|
RAPT
372
DELISTED
RAPT Therapeutics
RAPT
| $153K | 0.01% |
+4,515
| New | +$140K |
|
373
Arbutus Biopharma
ABUS
$907M
| $151K | 0.01% |
31,339
-2,263
| -7% | -$10.2K |
|
|
BCAX
374
Bicara Therapeutics
BCAX
$1.62B
| $150K | 0.01% |
+8,927
| New | +$152K |
|
375
CorMedix
CRMD
$557M
| $149K | 0.01% |
12,839
-246
| -2% | -$2.72K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q4 2025 Portfolio in Review
As of Q4 2025, China Universal Asset Management Company held 543 positions worth $1.3B, up 7.6% from $1.21B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
China Universal Asset Management Company's Q4 2025 filing shows 63 new, 193 increased, 214 reduced and 47 closed positions. Its largest new stake was Western Digital: 13,175 shares worth $2.27M. The largest sale was Broadcom, an estimated $11.5M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 40% a quarter earlier, followed by Healthcare and Communication Services.
- China Universal Asset Management Company's largest Q4 2025 buy was Western Digital: 13,175 shares worth $2.27M.
- China Universal Asset Management Company added most to ProShares Ultra Gold in Q4 2025, an estimated $16.2M increase.
- China Universal Asset Management Company's biggest Q4 2025 reduction was Broadcom, cutting an estimated $11.5M.
- China Universal Asset Management Company fully exited Royal Caribbean in Q4 2025, selling an estimated $2.72M.
- China Universal Asset Management Company's ten largest holdings make up 36% of its $1.3B portfolio in Q4 2025.
- China Universal Asset Management Company opened 63 new positions and closed 47 in Q4 2025.
- China Universal Asset Management Company's portfolio value rose 7.6% quarter-over-quarter to $1.3B.
Based on China Universal Asset Management Company's 13F filing for Q4 2025, filed 29 Jan 2026.